A paper published in the May/June issue of the Journal of Hospital Medicine shows that a collaborative approach to medication reconciliation (“med rec”) appears to both prevent adverse drug events and pay for itself.
The paper, “Nurse-Pharmacist Collaboration on Medication Reconciliation Prevents Potential Harm,” found that 225 of 500 surveyed patients had at least one unintended discrepancy in their house medication list (HML) on admission or discharge. And 162 of those patients had a discrepancy ranked on the upper end of the study’s risk scale.
However, having nurses and pharmacists work together “allowed many discrepancies to be reconciled before causing harm,” the study concluded.
“It absolutely supports the idea that we need to approach medicine as a team game,” says hospitalist and lead author Lenny Feldman, MD, FACP, FAAP, SFHM, of John Hopkins School of Medicine in Baltimore. “We can’t do this alone, and patients don’t do better when we do this alone.”
The study noted that it cost $113.64 to find one potentially harmful medication discrepancy. To offset those costs, an institution would have to prevent one discrepancy for every 290 patient encounters. The Johns Hopkins team averted 81 such events, but Dr. Feldman notes that without a control group, it’s difficult to say how many of those potential issues would have been caught at some other point in a patient’s stay.
Still, he says, part of the value of a multidisciplinary approach to med rec is that it can help hospitalists improve patient care. By having nurses, physicians, and pharmacists working together, more potential adverse drug events could be prevented, Dr. Feldman says.
“That data-gathering is difficult and time-consuming, and it is not something hospitalists need do on their own,” he adds.